Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.

PLoS One · 2014 · PMC3977817 · PMID 24710173

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a trend towards significancep = 0.09so close (0.05 < p ≤ 0.1)

There was a significant reduction in collagen Iα1 mRNA expression in the 25 mg/kg brivanib group (P<0.05) and a trend towards significance in the 50 mg/kg brivanib group (p = 0.09; one sided P value) ( Fig. 1C ).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.